Impact of adalimumab in patients with active non-infectious intermediate, posterior, and panuveitis in real-life clinical practice: HOPE study.
Pleyer U., Al-Mutairi S., Murphy C.C., Hamam R., Hammad S., Nagy O., Szepessy Z., Guex-Crosier Y., Julian K., Habot-Wilner Z. et al., 2023/11/22. The British journal of ophthalmology, 107 (12) pp. 1892-1899. Peer-reviewed.
ici le détail